BRIEF published on 02/16/2026 at 07:35, 5 months 22 days ago Nicox Receives Positive Feedback from FDA for NCX 470 NDA FDA Nicox Glaucoma Treatment NCX 470 NDA Submission
BRIEF published on 02/16/2026 at 07:35, 5 months 22 days ago Nicox reçoit un avis favorable de la FDA concernant sa demande d'autorisation de mise sur le marché (NDA) pour le NCX 470. FDA Nicox Traitement Du Glaucome NCX 470 Soumission D'un Accord De Confidentialité
BRIEF published on 02/16/2026 at 07:35, 5 months 22 days ago Nicox prépare une soumission de NDA pour NCX 470 après avis positif de la FDA FDA NDA Nicox NCX 470 Glaucome
PRESS RELEASE published on 02/16/2026 at 07:30, 5 months 22 days ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
PRESS RELEASE published on 02/16/2026 at 07:30, 5 months 22 days ago Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470 Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470, confirmant le dépôt de la NDA pour l'été 2026. Collaboration avec Kowa et avancée vers l'autorisation de mise sur le marché FDA Nicox NCX 470 Réunion Pré-NDA Autorisation De Marché
BRIEF published on 02/12/2026 at 07:35, 5 months 26 days ago Nicox maintient son statut PEA-PME pour 2026 PEA-PME Euronext Growth Paris Investissement Ophtalmologie Nicox
BRIEF published on 02/12/2026 at 07:35, 5 months 26 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
PRESS RELEASE published on 02/12/2026 at 07:30, 5 months 26 days ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour l'année à venir, permettant aux investisseurs de continuer à intégrer ses actions dans les comptes PEA PME PEA-PME Investissement Fiscalité Ophtalmologie Nicox
BRIEF published on 02/10/2026 at 07:35, 6 months ago Nicox présentera des données clés lors de la réunion annuelle de l'AGS en 2026. Essais Cliniques Nicox NCX 470 Glaucome AGS 2026
BRIEF published on 02/10/2026 at 07:35, 6 months ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
Published on 08/10/2026 at 15:30, 37 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 42 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 1 hour 37 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 2 hours 37 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 3 hours 7 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 15:56, 11 minutes ago Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
Published on 08/10/2026 at 15:46, 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/10/2026 at 15:44, 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/10/2026 at 11:53, 4 hours 13 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:53, 4 hours 13 minutes ago GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Published on 08/10/2026 at 11:36, 4 hours 30 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 11:36, 4 hours 30 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026
Published on 08/10/2026 at 09:47, 6 hours 20 minutes ago 260810 BENETEAU Transactions sur actions propres
